Views & Analysis | Perspectives on pharma industry issues

Digital

What US healthcare companies and medical researchers need to...

How Italy’s pioneering AI Law and the EU AI Act impacts US healthcare companies and medical researchers operating in Italy.

Market Access

JPM 2026: What it revealed about biotech’s new reality

JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.

Sales & Marketing

Pharma’s search loophole is a preview of what comes next

PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.

Digital

Sponsored

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

R&D

Clinical trials, various research areas, concept

Clinical Trials Round-Up – Jan to Feb 2026

Read how Jan-Feb '26 offered a revealing cross-section of how R&D is evolving across therapy areas.

R&D

Restoring sensitivity to targeted therapies

In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Steven Powell, CEO of Ribonexus, a new company put together to develop and ultimately commercialis

Patients

Reuters Pharma USA – Kevin Hagan

Working in the pharma industry, it’s important to be aware of the impact of policies on all stakeholders, from industry colleagues, to payers and providers, and to patients – including low-

Sales & Marketing

Sponsored

Empowering global and local brand teams with digital resourc...

Daniel Kohlstaedt, managing director and founder of PurpleLeaf Strategy, explores how moving resource planning into the cloud can lead to more simplified, streamlined, and optimised brand p

Sales & Marketing

Pharma’s search loophole is a preview of what comes next

PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.

Sales & Marketing

virtual electronic medical record interface

Sponsored

5 forces reshaping pharma commercialisation in 2026

As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment

Digital

What US healthcare companies and medical researchers need to...

How Italy’s pioneering AI Law and the EU AI Act impacts US healthcare companies and medical researchers operating in Italy.

Digital

Sponsored

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

Market Access

JPM 2026: What it revealed about biotech’s new reality

JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.

Market Access

What rare disease commercialisation in Europe teaches us - a...

Rare disease launches are the ultimate stress test for European commercialisation.

Oncology

Sponsored

Collaboration & personalisation in rare disease R&D, with AO...

For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.

Oncology